Hjem › Medulloblastom › Florida
Medulloblastom kliniske forsøg i Florida
6 studier for Medulloblastom søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- St. Joseph's Children's Hospital, Tampa
RekruttererFase 2
59 Months · Alle køn · Opdateret 15. sep. 2026 · NCT05535166Digoxin Medulloblastoma Study
- Nemours Jacksonville, Jacksonville
- University of Miami, Miami
- Johns Hopkins All Children's, St. Petersburg
- og 1 flere
RekruttererFase 2
12 Months – 30 Years · Alle køn · Opdateret 26. aug. 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
- Nemours Children's Clinic-Jacksonville, Jacksonville
- og 7 flere
RekruttererFase 3
Alder 4 til 21 · Alle køn · Opdateret 25. aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg
- og 1 flere
RekruttererFase 2
Op til 21 år · Alle køn · Opdateret 12. aug. 2026 · NCT04696029Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- University of Florida Health, Gainesville
RekruttererFase 1
Alder 4 til 30 · Alle køn · Opdateret 7. aug. 2026 · NCT06514898Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.